More importantly, mutation of the ERK2 SUMOylation sites further promoted cell growth, colony formation capacity, cell migration and invasion of breast cancer cells and tumorigenesis (Fig. 5), indicating the important role of ERK2 SUMOylation in the tumorigenesis of breast cancer. Here, MAPK1 is linked to breast carcinoma.